| Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ... Nature communications 11 (1), 3518, 2020 | 170 | 2020 |
| DIGGER: exploring the functional role of alternative splicing in protein interactions Z Louadi, K Yuan, A Gress, O Tsoy, OV Kalinina, J Baumbach, ... Nucleic acids research 49 (D1), D309-D318, 2021 | 38 | 2021 |
| BiCoN: Network-constrained biclustering of patients and omics data O Lazareva, S Canzar, K Yuan, J Baumbach, DB Blumenthal, P Tieri, ... Bioinformatics 37 (16), 2398-2404, 2021 | 20 | 2021 |
| TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factors M Hoffmann, N Trummer, L Schwartz, J Jankowski, HK Lee, LL Willruth, ... GigaScience 12, giad026, 2023 | 3 | 2023 |
| Distinct patterns of vital sign and inflammatory marker responses in adults with suspected bloodstream infection Q Gu, J Wei, CH Yoon, K Yuan, N Jones, A Brent, M Llewelyn, TEA Peto, ... Journal of Infection 88 (5), 106156, 2024 | 2 | 2024 |
| Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data L Chammas, K Yuan, S Little, G Roadknight, KA Varnai, SC Chang, S Sze, ... Frontiers in Cardiovascular Medicine 11, 1406608, 2024 | | 2024 |
| Leveraging transformers and large language models with antimicrobial prescribing data to predict sources of infection for electronic health record studies K Yuan, CH Yoon, Q Gu, H Munby, AS Walker, T Zhu, D Eyre medRxiv, 2024.04. 17.24305966, 2024 | | 2024 |
| Targeting infectious diseases: The CoVex example S Sadegh, J Matschinske, DB Blumenthal, G Galindez, T Kacprowski, ... RExPO22, 2022 | | 2022 |
